肝切除术前肝脏储备功能的评估及研究进展
Assessment and Research Progress of Liver Reserve Function before Hepatectomy
DOI: 10.12677/ACM.2021.119602, PDF,   
作者: 刘洪恩, 任 利*:青海大学附属医院肝胆胰外科,青海 西宁
关键词: 肝脏肝脏储备功能评估肝功能肝切除Liver Liver Reserve Function Assessment Liver Function Hepatectomy
摘要: 术后肝脏衰竭仍然是肝脏手术的主要并发症之一。肝功能的术前评价对于降低肝切除或肝移植术后的并发症至关重要。随着医疗技术的发展及精准肝脏切除理念的提出,术前肝脏储备功能的评估显得越来越重要。目前应用于肝脏储备功能评估的各种方法主要包括血清学指标、临床评分系统(如Child-Pugh、MELD评分和白蛋白–胆红素(ALBI)评分)、动态定量检测肝脏清除功能(如吲哚箐绿清除试验)、CT容量评估等。目前针对评价肝功能的检查方法很多,但是没有哪一种评估方法能够全面且精准有效地评价肝脏储备功能。因此,需要结合多种检查方法以更加全面地评价肝脏储备功能。本文针对肝脏储备功能评估检查新近进展予以综述。
Abstract: Postoperative liver failure is still one of the main complications of liver surgery. Preoperative evaluation of liver function is critical to reducing complications after liver resection or liver transplantation. With the development of medical technology and the proposal of precise liver resection, the evaluation of preoperative liver reserves is more important. The various methods currently applied to the liver reserve functional assessment mainly include serological indicators, clinical scoring systems (such as Child-Pugh, MELD rating and albumin-bilirubin (ALBI) score), dynamic quantitative detection of liver clearance function (such as indocyanine green retention test), CT capacity assessment, etc. There are currently a lot of inspection methods for evaluating liver function, but no evaluation method can comprehensively and accurately evaluate liver reserves. Therefore, there is a need to combine a variety of inspection methods to the more comprehensive evaluation of liver reserves. This paper summarizes new progress on the evaluation of liver reserves.
文章引用:刘洪恩, 任利. 肝切除术前肝脏储备功能的评估及研究进展[J]. 临床医学进展, 2021, 11(9): 4127-4134. https://doi.org/10.12677/ACM.2021.119602

参考文献

[1] Schindl, M.J., et al. (2006) The Adaptive Response of the Reticuloendothelial System to Major Liver Resection in Humans. Annals of Surgery, 243, 507-514. [Google Scholar] [CrossRef] [PubMed]
[2] Benjamin, N., et al. (2016) Delayed Diagnosis of Alpha-1-Antitrypsin Deficiency Following Post-Hepatectomy Liver Failure: A Case Report. World Journal of Gastroenterology, 22, 3289-3295. [Google Scholar] [CrossRef] [PubMed]
[3] Chand, N. and Sanyal, A.J. (2007) Sepsis-Induced Cholestasis. Hepatology, 45, 230-241. [Google Scholar] [CrossRef] [PubMed]
[4] Kathryn, M. (2008) Field and Chris Dow and Michael Michael. Part I: Liver Function in Oncology: Biochemistry and beyond. The Lancet Oncology, 9, 1092-1101. [Google Scholar] [CrossRef
[5] Koo, K.Y., Kim, D.K., Cui, J., et al. (2008) Hepatocellular carcinoma. World Scientific Publishing, Singapore, 834-840.
[6] Child, C.G. and Turcotte, J. (1979) Surgery and Portal Hypertension. Clinics in Gastroenterology, 8, 525-541. [Google Scholar] [CrossRef
[7] Pugh, R.N., Murray-Lyon, I.M., Dawson, J.L., et al. (1973) Transection of the Oesophagus for Bleeding Oesophageal Varices. The British Journal of Surgery, 60, 646-649. [Google Scholar] [CrossRef] [PubMed]
[8] Malinchoc, M., et al. (2000) A Model to Predict Poor Survival in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunts. Hepatology (Baltimore, Md.), 31, 864-871. [Google Scholar] [CrossRef] [PubMed]
[9] Philipp, D., et al. (2011) The Model for End-Stage Liver Disease Allocation System for Liver Transplantation Saves Lives, But Increases Morbidity and Cost: A Prospective Outcome Analysis. Liver Transplantation, 17, 674-684. [Google Scholar] [CrossRef] [PubMed]
[10] Biggins, S.W., et al. (2006) Evidence-Based Incorporation of Serum Sodium Concentration into MELD. Gastroenterology, 130, 1652-1660. [Google Scholar] [CrossRef] [PubMed]
[11] Kim, W.R., et al. (2008) Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List. New England Journal of Medicine, 359, 1018-1026. [Google Scholar] [CrossRef
[12] Teh-Ia, H., et al. (2008) Comparison of Four Model for End-Stage Liver Disease-Based Prognostic Systems for Cirrhosis. Liver Transplantation, 14, 837-844. [Google Scholar] [CrossRef] [PubMed]
[13] Mizuguchi, T., et al. (2014) Preoperative Liver Function Assessments to Estimate the Prognosis and Safety of Liver Resections. Surgery Today, 44, 1-10. [Google Scholar] [CrossRef] [PubMed]
[14] Abradelo, M. and Jimenez, C. (2013) Splitting Liver Grafts for Two Adults: Suboptimal Grafts or Suboptimal Matching? Hepatobiliary Surgery and Nutrition, 2, 242-243.
[15] Bruix, J. and Sherman, M. (2011) Management of Hepatocellular Carcinoma: An Update. Hepatology, 53, 1020-1022. [Google Scholar] [CrossRef] [PubMed]
[16] Johnson, P.J., et al. (2015) Assessment of Liver Function in Patients with Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade. Journal of Clinical Oncology, 33, 550-558. [Google Scholar] [CrossRef
[17] Schneider, P.D. (2004) Preoperative Assessment of Liver Function. Surgical Clinics of North America, 84, 355-373. [Google Scholar] [CrossRef
[18] Paumgartner, G. (1975) The Handling of Indocyanine Green by the Liver. Schweizerische Medizinische Wochenschrift, 105, 1-30.
[19] Akita, H., et al. (2008) Real-Time Intraoperative Assessment of Residual Liver Functional Reserve Using Pulse Dye Densitometry. World Journal of Surgery, 32, 2668-2674. [Google Scholar] [CrossRef] [PubMed]
[20] Wissler, E.H. (2011) Identifying a Long Standing Error in Single-Bolus Determination of the Hepatic Extraction Ratio for Indocyanine Green. European Journal of Applied Physiology, 111, 641-646. [Google Scholar] [CrossRef] [PubMed]
[21] Bernal, W., et al. (2002) Blood Lactate as an Early Predictor of Outcome in Paracetamol-Induced Acute Liver Failure: A Cohort Study. The Lancet, 359, 558-563. [Google Scholar] [CrossRef
[22] Sathirakul, K., et al. (1993) Kinetic Analysis of Hepatobiliary Transport of Organic Anions in Eisai Hyperbilirubinemic Mutant Rats. The Journal of Pharmacology and Experimental Therapeutics, 265, 1301-1312.
[23] Kusuhara and Sugiyama (2010) Pharmacokinetic Modeling of the Hepatobiliary Transport Mediated by Cooperation of Uptake and Efflux Transporters. Drug Metabolism Reviews, 42, 539-550. [Google Scholar] [CrossRef] [PubMed]
[24] Imamura, H., et al. (2005) Assessment of Hepatic Reserve for Indication of Hepatic Resection: Decision Tree Incorporating Indocyanine Green Test. Journal of Hepato-Biliary-Pancreatic Surgery, 12, 16-22. [Google Scholar] [CrossRef] [PubMed]
[25] de Graaf, W., et al. (2011) Transporters Involved in the Hepatic Uptake of 99mTc-Mebrofenin and Indocyanine Green. Journal of Hepatology, 54, 738-745. [Google Scholar] [CrossRef] [PubMed]
[26] Kawasaki, S., et al. (1988) Hepatic Clearances of Antipyrine, Indocyanine Green, and Galactose in Normal Subjects and in Patients with Chronic Liver Diseases. Clinical Pharmacology and Therapeutics, 44, 217-224. [Google Scholar] [CrossRef] [PubMed]
[27] Das, B.C., Isaji, S. and Kawarada, Y. (2001) Analysis of 100 Consecutive Hepatectomies: Risk Factors in Patients with Liver Cirrhosis or Obstructive Jaundice. World Journal of Surgery, 25, 266-273. [Google Scholar] [CrossRef] [PubMed]
[28] Lau, H., et al. (1997) Evaluation of Preoperative Hepatic Function in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy. British Journal of Surgery, 84, 1255-1259. [Google Scholar] [CrossRef] [PubMed]
[29] Faybik, P. and Hetz, H. (2006) Plasma Disappearance Rate of Indocyanine Green in Liver Dysfunction. Transplantation Proceedings, 38, 801-802. [Google Scholar] [CrossRef] [PubMed]
[30] Fan, S.T., et al. (1995) Hospital Mortality of Major Hepatectomy for Hepatocellular Carcinoma Associated with Cirrhosis. Archives of Surgery (Chicago, Ill.: 1960), 130, 198-203. [Google Scholar] [CrossRef] [PubMed]
[31] Lam, C.M., et al. (1999) Major Hepatectomy for Hepatocellular Carcinoma in Patients with an Unsatisfactory Indocyanine Green Clearance Test. British Journal of Surgery, 86, 1012-1017. [Google Scholar] [CrossRef] [PubMed]
[32] Caesar, J., et al. (1961) The Use of Indocyanine Green in the Measurement of Hepatic Blood Flow and as a Test of Hepatic Function. Clinical Science, 21, 43-57.
[33] Tarantino, G. (2009) Could Quantitative Liver Function Tests Gain Wide Acceptance among Hepatologists? World Journal of Gastroenterology, 15, 3457-3461. [Google Scholar] [CrossRef] [PubMed]
[34] Tygstrup, N. (1966) Determination of the Hepatic Elimination Capacity (Lm) of Galactose by Single Injection. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum, 18, 118-125.
[35] Jepsen, P., et al. (2009) The Galactose Elimination Capacity and Mortality in 781 Danish Patients with Newly-Diagnosed Liver Cirrhosis: A Cohort Study. BMC Gastroenterology, 9, Article No. 50. [Google Scholar] [CrossRef
[36] Redaelli, C.A., Dufour, J.F., Wagner, M., Schilling, M., Hüsler, J., Krähenbühl, L., et al. (2002) Preoperative Galactose Elimination Capacity Predicts Complications and Survival after Hepatic Resection. Annales de Chirurgie, 127, 407-408. [Google Scholar] [CrossRef
[37] Urata, K., et al. (1995) Calculation of Child and Adult Standard Liver Volume for Liver Transplantation. Hepatology, 21, 1317-1321. [Google Scholar] [CrossRef] [PubMed]
[38] Hshieh, T.T. and Sundaram, V. (2013) Liver Transplantation for Hepatocellular Carcinoma: Are International Guidelines Possible? Hepatobiliary Surgery and Nutrition, 2, 113-116.
[39] Shoup, M., et al. (2003) Volumetric Analysis Predicts Hepatic Dysfunction in Patients Undergoing Major Liver Resection. Journal of Gastrointestinal Surgery, 7, 325-330. [Google Scholar] [CrossRef
[40] Schindl, M.J., et al. (2005) The Value of Residual Liver Volume as a Predictor of Hepatic Dysfunction and Infection after Major Liver Resection. Gut, 54, 289-296. [Google Scholar] [CrossRef] [PubMed]
[41] Bruix, J. and Sherman, M. (2005) Management of Hepatocellular Carcinoma: An Update. Hepatology, 53, 1208-1236. [Google Scholar] [CrossRef] [PubMed]